Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

5-HT7 receptor activation inhibits mechanical hypersensitivity secondary to capsaicin sensitization in mice

Brenchat, Alexa; Romero, Luza; García, Mónicaa; Pujol, Martaa; Burgueño, Javiera; Torrens, Antonia; Hamon, Michelb; Baeyens, José Manuelc; Buschmann, Helmuta; Zamanillo, Daniela; Vela, José Miguela,*

doi: 10.1016/j.pain.2008.11.009

ABSTRACT This work aimed to evaluate the potential role of the 5-HT7 receptor in nociception secondary to a sensitizing stimulus in mice. For this purpose, the effects of relevant ligands (5-HT7 receptor agonists: AS-19, MSD-5a, E-55888; 5-HT7 receptor antagonists: SB-258719, SB-269970; 5-HT1A receptor agonist: F-13640; 5-HT1A receptor antagonist: WAY-100635) were assessed on capsaicin-induced mechanical hypersensitivity, a pain behavior involving hypersensitivity of dorsal horn neurons (central sensitization). For the 5-HT7 receptor agonists used, binding profile and intrinsic efficacy to stimulate cAMP formation in HEK-293F cells expressing the human 5-HT7 receptor were also evaluated. AS-19 and E-55888 were selective for 5-HT7 receptors. E-55888 was a full agonist whereas AS-19 and MSD-5a behaved as partial agonists, with maximal effects corresponding to 77% and 61%, respectively, of the cAMP response evoked by the full agonist 5-HT. Our in vivo results revealed that systemic administration of 5-HT7 receptor agonists exerted a clear-cut dose-dependent antinociceptive effect that was prevented by 5-HT7 receptor antagonists, but not by the 5-HT1A receptor antagonist. The order of efficacy (E-55888 > AS-19 > MSD-5a) matched their in vitro efficacy as 5-HT7 receptor agonists. Contrary to agonists, a dose-dependent promotion of mechanical hypersensitivity was observed after administration of 5-HT7 receptor antagonists, substantiating the involvement of the 5-HT7 receptor in the control of capsaicin-induced mechanical hypersensitivity. These findings suggest that serotonin exerts an inhibitory role in the control of nociception through activation of 5-HT7 receptors, and point to a new potential therapeutic use of 5-HT7 receptor agonists in the field of analgesia.

aLaboratorios Esteve, Department of Pharmacology, Av. Mare de Déu de Montserrat, 221, 08041 Barcelona, Spain

bUMR 677 INSERM/UPMC, Faculté de Médecine Pierre et Marie Curie, Site Pitié-Salpêtrière, 91 Boulevard de l’hôpital, 75634 Paris Cedex 13, France

cDepartmento de Farmacología e Instituto de Neurociencias, Facultad de Medicina, Universidad de Granada, Av. de Madrid, 11, 18012 Granada, Spain

*Corresponding author. Tel.: +34 93 4466244; fax: +34 93 4466220.



Article history:

Received April 29, 2008

Received in revised form October 20, 2008

Accepted November 10, 2008.

© 2009 Lippincott Williams & Wilkins, Inc.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website